3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Sarcoma, Ewing
1
Sarcoma
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Male Urogenital Diseases
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Financial Stress
1
Female Urogenital Diseases
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
7
Specimen Handling
6
Human Papillomavirus DNA Tests
4
Colposcopy
4
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Fulvestrant
3
Cisplatin
3
Carboplatin
3
palbociclib
2
lenvatinib
2
Surveys and Questionnaires
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Magnetic Resonance Imaging
2
Gemcitabine
2
Biopsy
2
Bevacizumab
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
tisotumab vedotin
1
sapanisertib
1
ribociclib
1
relatlimab
1
pertuzumab
1
patritumab deruxtecan
1
osimertinib
1
omipalisib
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Radiation Dose Hypofractionation
×
30 days
×
Clear all
NCT07605507
2026-05-26
HYPOCx-iRex
Siriraj Hospital
Phase NA
Active not recruiting
40 enrolled
NCT07595224
2026-05-19
PostOP HYPOCxE
Siriraj Hospital
Phase NA
Recruiting
120 enrolled